A Study To Characterize The Pharmacokinetics Of Oxycodone In Healthy Volunteers

Completed · Phase 1

Conditions studied: Pain

In brief

This is an open-label (both the physician and healthy volunteer know which medication will be administered), single-dose, 6- dosing period study to characterize the pharmacokinetics of oxycodone (process by which oxycodone is absorbed, distributed, metabolized, and eliminated by the body). This study will consist of three parts that will take place over approximately 90 days. Part 1 of the study has 4 dosing periods, while Parts 2 and 3 have one dosing period each.

Key facts

Study ID

NCT01552863

Run by

Pain Therapeutics

People needed

21

Starts

2012-03-01

Expected to finish

2012-09-01

Last updated by the study team

2015-08-31

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy male and/or female subjects between 18 and 55 years of age (inclusive).

You may not qualify if…

• Evidence or history of clinically significant disease.
• History of obstructive sleep apnea.
• Positive urine drug test.

Where it is running

• Pfizer Investigational Site — New Haven, Connecticut, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.